ZA200200731B - Novel strategy for carbohydrate-based therapeutic vaccines. - Google Patents

Novel strategy for carbohydrate-based therapeutic vaccines.

Info

Publication number
ZA200200731B
ZA200200731B ZA200200731A ZA200200731A ZA200200731B ZA 200200731 B ZA200200731 B ZA 200200731B ZA 200200731 A ZA200200731 A ZA 200200731A ZA 200200731 A ZA200200731 A ZA 200200731A ZA 200200731 B ZA200200731 B ZA 200200731B
Authority
ZA
South Africa
Prior art keywords
carbohydrate
based therapeutic
therapeutic vaccines
novel strategy
strategy
Prior art date
Application number
ZA200200731A
Inventor
Harold J Jennings
Subash Sad
Zhongwu Guo
Tianmin Liu
Qingling Yang
Original Assignee
Ca Nat Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ca Nat Research Council filed Critical Ca Nat Research Council
Publication of ZA200200731B publication Critical patent/ZA200200731B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001169—Tumor associated carbohydrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA200200731A 1999-07-29 2002-01-28 Novel strategy for carbohydrate-based therapeutic vaccines. ZA200200731B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002279134A CA2279134A1 (en) 1999-07-29 1999-07-29 Novel strategy for carbohydrate-based therapeutic vaccines

Publications (1)

Publication Number Publication Date
ZA200200731B true ZA200200731B (en) 2003-03-26

Family

ID=4163882

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200200731A ZA200200731B (en) 1999-07-29 2002-01-28 Novel strategy for carbohydrate-based therapeutic vaccines.

Country Status (8)

Country Link
EP (1) EP1198244A2 (en)
JP (1) JP2003506034A (en)
AU (1) AU6420000A (en)
CA (1) CA2279134A1 (en)
IL (1) IL147776A0 (en)
MX (1) MXPA02000958A (en)
WO (1) WO2001009298A2 (en)
ZA (1) ZA200200731B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2417574A1 (en) * 2000-07-28 2002-02-07 National Research Council Of Canada Modified sialic acid vaccines
CA2399325A1 (en) * 2001-08-21 2003-02-21 National Research Council Of Canada Carbohydrate-based whole cell cancer vaccines
US8148335B2 (en) 2004-06-23 2012-04-03 Children's Hospital & Research Center Oakland De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
US7595307B2 (en) * 2004-06-23 2009-09-29 Children's Hospital And Research Center At Oakland Polysaccharide derivatives and uses in induction of an immune response
MX2008008185A (en) * 2005-12-23 2008-11-14 Childrens Hosp & Res Ct Oak De-n-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy.
US8414899B2 (en) 2006-04-11 2013-04-09 Yeda Research And Development Co. Ltd. Vaccines comprising multimeric HSP60 peptide carriers
JP5597130B2 (en) * 2007-07-03 2014-10-01 チルドレンズ ホスピタル アンド リサーチ センター アット オークランド Inhibitors of polysialic acid de-N-acetylase and methods of use thereof
WO2009006613A1 (en) 2007-07-03 2009-01-08 Children's Hospital & Research Center At Oakland Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targeting
AU2008272792B2 (en) 2007-07-03 2014-03-06 Children's Hospital & Research Center At Oakland Oligosialic acid derivatives, methods of manufacture, and immunological uses
US8640245B2 (en) 2010-12-24 2014-01-28 Kaspersky Lab, Zao Optimization of anti-malware processing by automated correction of detection rules

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5102663A (en) * 1988-10-18 1992-04-07 Sloan-Kettering Instutute For Cancer Research Vaccine for stimulating or enhancing production of antibodies against 9-O-acetyl GD3
US5811102A (en) * 1995-06-07 1998-09-22 National Research Council Of Canada Modified meningococcal polysaccharide conjugate vaccines

Also Published As

Publication number Publication date
JP2003506034A (en) 2003-02-18
MXPA02000958A (en) 2003-07-21
IL147776A0 (en) 2002-08-14
WO2001009298A3 (en) 2001-08-23
AU6420000A (en) 2001-02-19
WO2001009298A2 (en) 2001-02-08
EP1198244A2 (en) 2002-04-24
CA2279134A1 (en) 2001-01-29

Similar Documents

Publication Publication Date Title
HK1200316A1 (en) Therapeutic microfoams
IL145043A0 (en) Vaccine
HUP0202885A3 (en) Vaccines
HUS1300072I1 (en) Vaccine
GB9907243D0 (en) Therapy
ZA200200731B (en) Novel strategy for carbohydrate-based therapeutic vaccines.
GB9915204D0 (en) Vaccine
GB9901254D0 (en) Vaccines
ZA200110046B (en) Therapeutic agents.
MXPA01010701A (en) Vaccine.
GB9906437D0 (en) Vaccine
GB9930591D0 (en) Component for vaccine
GB9913327D0 (en) Vaccine
GB9909072D0 (en) Vaccine
GB9919260D0 (en) Vaccine
GB9922700D0 (en) Vaccine
GB9915205D0 (en) Vaccine
GB9915106D0 (en) Vaccine
GB9917144D0 (en) Vaccine
GB9918647D0 (en) Vaccine
GB9904408D0 (en) Vaccine
GB9916677D0 (en) Vaccine
GB9922701D0 (en) Vaccine
GB9927336D0 (en) Vaccine
GB9905511D0 (en) Vaccine